Yuhan Corp is making aggressive investments in its US subsidiary. Investing ₩23.1 billion during the past 4 years after establishing Yuhan USA in 2018, the company has been making broad steps to advance into the global market.

According to the Financial Supervisory Service on the 17th, Yuhan Corp had invested ₩7.7 billion in Yuhan USA, and acquired 6 million shares in the second quarter of this year.

Yuhan USA, which was established in 2018, is the regional subsidiary of Yuhan Corp that is responsible for investing in promising bio-ventures, global clinical trials, and technology exports. As a fully-owned subsidiary of Yuhan Corp, it has been serving as the bridgehead for the